Anti-WDR82 monoclonal antibody

Pre-made anti-WDR82 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to WDR82/WDR82 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2278-Ab-1/ GM-Tg-hg-IP2278-Ab-2Anti-Human WDR82 monoclonal antibodyHuman
GM-Tg-rg-IP2278-Ab-1/ GM-Tg-rg-IP2278-Ab-2Anti-Rat WDR82 monoclonal antibodyRat
GM-Tg-mg-IP2278-Ab-1/ GM-Tg-mg-IP2278-Ab-2Anti-Mouse WDR82 monoclonal antibodyMouse
GM-Tg-cynog-IP2278-Ab-1/ GM-Tg-cynog-IP2278-Ab-2Anti-Cynomolgus/ Rhesus macaque WDR82 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2278-Ab-1/ GM-Tg-felg-IP2278-Ab-2Anti-Feline WDR82 monoclonal antibodyFeline
GM-Tg-cang-IP2278-Ab-1/ GM-Tg-cang-IP2278-Ab-2Anti-Canine WDR82 monoclonal antibodyCanine
GM-Tg-bovg-IP2278-Ab-1/ GM-Tg-bovg-IP2278-Ab-2Anti-Bovine WDR82 monoclonal antibodyBovine
GM-Tg-equg-IP2278-Ab-1/ GM-Tg-equg-IP2278-Ab-2Anti-Equine WDR82 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2278-Ab-1/ GM-Tg-hg-IP2278-Ab-2; GM-Tg-rg-IP2278-Ab-1/ GM-Tg-rg-IP2278-Ab-2;
GM-Tg-mg-IP2278-Ab-1/ GM-Tg-mg-IP2278-Ab-2; GM-Tg-cynog-IP2278-Ab-1/ GM-Tg-cynog-IP2278-Ab-2;
GM-Tg-felg-IP2278-Ab-1/ GM-Tg-felg-IP2278-Ab-2; GM-Tg-cang-IP2278-Ab-1/ GM-Tg-cang-IP2278-Ab-2;
GM-Tg-bovg-IP2278-Ab-1/ GM-Tg-bovg-IP2278-Ab-2; GM-Tg-equg-IP2278-Ab-1/ GM-Tg-equg-IP2278-Ab-2
Products NameAnti-WDR82 monoclonal antibody
Formatmab
Target NameWDR82
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-WDR82 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2278-Ag-1Recombinant multi-species WDR82/ MST107/ MSTP107 protein


    Target information

    Target IDGM-IP2278
    Target NameWDR82
    Gene ID80335,77305,686295,697708,484740,101081529,783336,100060351
    Gene Symbol and Synonyms9430077D24Rik,CDW5/WDR82,MST107,MSTP107,PRO2730,PRO34047,SWD2,™EM113,WDR82,WDR82A,WDR82P1
    Uniprot AccessionQ6UXN9
    Uniprot Entry NameWDR82_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000164091
    Target ClassificationN/A

    The target: WDR82, gene name: WDR82, also named as MST107, MSTP107, PRO2730, PRO34047, SWD2, ™EM113A, WDR82. ™EM113 (WDR82) is a component of the mammalian SET1A (MIM 611052)/SET1B (MIM 611055) histone H3-Lys4 methyltransferase complexes (Lee and Skalnik, 2005 [PubMed 16253997]; Lee et al., 2007 [PubMed 17355966]).[supplied by OMIM, Jul 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.